Understand the source comparison
Thymalin Dosage Thymus Support 2026: Comparison Table
| Protocol Structure | Dosage | Cycle Length | Administration Timing | Expected CD4+ Change | Sustained Effect Duration | Professional Assessment ||—|—|—|—|—|—|| Pulse-Cycle Standard | 10mg daily | 10 days, quarterly | 7–9 AM (cortisol peak) | +18–24% from bas
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Protocol Structure | Dosage | Cycle Length | Administration Timing | Expected CD4+ Change | Sustained Effect Duration | Professional Assessment ||—|—|—|—|—|—|| Pulse-Cycle Standard | 10mg daily | 10 days, quarterly | 7–9 AM (cortisol peak) | +18–24% from baseline | 60–75 days post-cycle | Evidence-supported protocol. Matches physiological thymic burst pattern and prevents receptor downregulation || Continuous Low-Dose | 5mg daily | 30+ days ongoing | Variable | +8–12% from baseline | Returns to baseline within 30 days of stopping | Poor long-term efficacy. Chronic stimulation triggers receptor downregulation and homeostatic adaptation || High-Dose Pulse | 20mg daily | 10 days, quarterly | 7–9 AM (cortisol peak) | +19–26% from baseline | 60–75 days post-cycle | Marginal benefit over 10mg standard protocol at double compound cost. Receptor saturation limits additional gains || Evening Administration | 10mg daily | 10 days, quarterly | 6–9 PM (low cortisol) | +9–14% from baseline | 35–4